Bryan Severyn

Bryan Severyn is currently a Senior Scientist at Merck & Co., specializing in exploratory molecular-based assays within the Department of Pharmacokinetics, Dynamics, Metabolism and Bioanalytics. Previously, they held various scientific roles, including Senior Research Scientist at Immunome, Inc., where they focused on identifying novel tumor-targeting antibodies, and a Senior Scientist at Merck from 2006 to 2016, contributing to antiviral and small molecule screening efforts. Bryan's early career include positions as a Research Assistant at Thomas Jefferson University and Exygen Inc., where they developed multiple high-throughput screening methods. They earned a Master of Science in Entomology and a Bachelor of Science in Microbiology from The Pennsylvania State University and are currently a certified Project Manager.